Gestational Diabetes Mellitus GDM Test51+ booked in last 3 days
The 2-Step Procedure for Screening and Diagnosis of Gestational Diabetes Mellitus (ADA) is a recommended method for identifying individuals who have gestational diabetes.
Step 1 is a screening test, typically done between 24-28 weeks of pregnancy. The screening test is called the Oral Glucose Tolerance Test (OGTT). The test involves drinking a sugary liquid and having blood sugar levels measured one hour later. If the level is higher than a certain threshold, it is considered abnormal and patient move to step 2.
Step 2 is a diagnostic test, which is called the Oral Glucose Tolerance Test (OGTT). The test is done in a similar way to the screening test, but it involves taking blood sugar measurements at multiple times over a period of three hours. If two or more of the blood sugar measurements are above certain thresholds, it is considered diagnostic of gestational diabetes.
It's important to note that the diagnostic criteria for gestational diabetes may vary depending on the source and the guidelines. The ADA criteria for the diagnosis of gestational diabetes are widely used, but other organizations may have slightly different criteria.
- Glucose Tolerance Test 3 samples for glucose and insulin
- Glucose Tolerance Test 2 hours 2 samples
- Glucose Tolerance Test 2 hours 3 sample
- GTT-Gestational, Three Hour (100 grams glucose)
- Glucose Tolerance Test 2.5 hours 5 samples
- Glucose Tolerance Test 5 hours 8 samples
Written by : Supriya Kulkarni, Lead-Content & Training
Gestational Diabetes Mellitus GDM Test Price
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Gestational Diabetes Mellitus GDM Test with a clear pricing structure.
The Gestational Diabetes Mellitus GDM Test Price in Mumbai is ₹ 315 .
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
Why is 2 step procedure for Screening and diagnosis of Gestational Diabetes Mellitus(ADA) test Done?
The 2-Step Procedure for Screening and Diagnosis of Gestational Diabetes Mellitus (ADA) is done to identify individuals who have gestational diabetes, which is a type of diabetes that develops during pregnancy. Gestational diabetes is caused by changes in the way a woman's body uses insulin during pregnancy. These changes can cause blood sugar levels to become too high, which can lead to a number of potential complications for both the mother and the baby.
It is important to identify and manage gestational diabetes as early as possible in pregnancy to reduce the risk of these complications. Some of the potential complications include:
- Excess birth weight in the baby
- Increased risk of Caesarean delivery
- Increased risk of respiratory distress syndrome and other complications in the baby
- Increased risk of high blood pressure and preeclampsia in the mother
By identifying and managing gestational diabetes early in pregnancy, healthcare providers can take steps to reduce the risk of these complications and ensure the best possible outcome for both the mother and the baby.
Who should get 2 step procedure for Screening and diagnosis of Gestational Diabetes Mellitus(ADA)test done?
The 2-Step Procedure for Screening and Diagnosis of Gestational Diabetes Mellitus (ADA) is typically recommended for all pregnant individuals. However, there are certain individuals who are at higher risk for gestational diabetes and may be more likely to benefit from the screening and diagnosis. The American Diabetes Association (ADA) recommends that all pregnant individuals be screened for gestational diabetes between 24-28 weeks of pregnancy, but some individuals may need to be screened earlier or more frequently based on their risk factors.
Risk factors for gestational diabetes include:
- Previous diagnosis of gestational diabetes
- Family history of diabetes
- Previous delivery of a large baby
- A history of impaired glucose tolerance or impaired fasting glucose
- A history of polycystic ovary syndrome (PCOS)
It's important to note that even if a person does not have any risk factors, gestational diabetes can still occur, that's why the screening is recommended for all pregnant individuals.
What does 2 step procedure for Screening and diagnosis of Gestational Diabetes Mellitus(ADA) measure?
The 2-Step Procedure for Screening and Diagnosis of Gestational Diabetes Mellitus (ADA) measures blood sugar levels in pregnant individuals to identify those who have gestational diabetes.
What to expect during 2 step procedure for Screening and diagnosis of Gestational Diabetes Mellitus(ADA) test?
This test requires a blood sample. A tourniquet (elastic) band is placed tightly on the upper arm. The patient is then asked to make a fist. This helps in the build-up of blood filling the veins. The skin is disinfected before needle insertion and the blood sample is collected in vacutainer.
What if 2 step procedure for Screening and diagnosis of Gestational Diabetes Mellitus(ADA) results are Present/ Absent?
If the 2-Step Procedure for Screening and Diagnosis of Gestational Diabetes Mellitus (ADA) tests positive, it indicates that the individual has gestational diabetes. This means that the individual has high blood sugar levels during pregnancy. It is important for individuals with gestational diabetes to work closely with their healthcare provider to manage their blood sugar levels and reduce the risk of complications for themselves and their baby. This may include following a healthy diet, regular physical activity, and potentially taking medication to manage blood sugar levels.
Ratings & Reviews (0)
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.